Trademark: 86934766
Status Date
Saturday, March 16, 2024
Registration Number
5324671
Registration Date
Tuesday, October 31, 2017
Filing Date
Wednesday, March 9, 2016
Published for Opposition
Tuesday, August 2, 2016
5 Pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders
Mar 16, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Mar 16, 2024
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Mar 16, 2024
Case Assigned To Post Registration Paralegal
Jan 24, 2024
Automatic Update Of Assignment Of Ownership
Sep 21, 2023
Teas Section 8 & 15 Received
Oct 31, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 23, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 23, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 31, 2017
Registered-Principal Register
Sep 26, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 23, 2017
Allowed Principal Register - Sou Accepted
Sep 14, 2017
Statement Of Use Processing Complete
Aug 25, 2017
Use Amendment Filed
Sep 13, 2017
Case Assigned To Intent To Use Paralegal
Aug 25, 2017
Teas Statement Of Use Received
Mar 29, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 27, 2017
Sou Extension 1 Granted
Mar 27, 2017
Sou Extension 1 Filed
Mar 27, 2017
Sou Teas Extension Received
Sep 27, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2016
Published For Opposition
Jul 13, 2016
Notification Of Notice Of Publication E-Mailed
Jun 21, 2016
Approved For Pub - Principal Register
Jun 21, 2016
Assigned To Examiner
Mar 15, 2016
New Application Office Supplied Data Entered
Mar 12, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
